Genmab CLO Birgitte Stephensen to retire, Greg Mueller to succeed

Genmab (GMAB) announced that Birgitte Stephensen, EVP and Chief Legal Officer, will retire from Genmab after a tenure that spanned 23 years with the company. Greg Mueller joins Genmab as EVP, General Counsel and CLO effective July 1. He will report directly to Genmab’s President and CEO Jan van de Winkel and be based in Copenhagen, Denmark. Greg will join Jan and the rest of the Executive Committee, including CMO Tahi Ahmadi, CCO Brad Bailey, CPO Chris Cozic, CDO Judith Klimovsky, CFO Anthony Pagano, CSO Martine van Vugt, and Chief TechOps Officer Rayne Waller. Greg joins Genmab from AstraZeneca (AZN), where he spent more than 20 years working in North America, Europe and Asia. For the last 12 years, he was part of the Legal Senior Management Team, holding roles as the Deputy General Counsel, International and then as the Deputy General Counsel, Corporate.